Abstract
A clinical decision report appraising Janssen CA, Voshaar MAHO, Vonkeman HE, et al. Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial. Rheumatology. 2019;58(8):1344-1352. https://doi.org/10.1093/rheumatology/key402 for a patient with an acute gouty attack refractory to standard treatment.
DOI
10.22237/crp/1593562920
Creative Commons License
This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License
Recommended Citation
CRAIG C. IL-1 inhibitor anakinra is an effective alternative to standard treatments for reducing pain due to acute gout flare. Clin. Res. Prac. Oct 16 2020;6(2):eP2345. https://doi.org/10.22237/crp/1593562920
Included in
Medical Education Commons, Musculoskeletal Diseases Commons, Rheumatology Commons, Translational Medical Research Commons
